Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial - Concepedia

Concepedia

Publication | Open Access

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

DOI Full Paper Access

59

Citations

29

References

2016

Year

Daniel F. Hoft, Azra Blazevic, Asmir Selimovic, Aldin Turan, Jan Tennant, Getahun Abate, John P. Fulkerson, Daniel E. Zak, Robert Walker, Bruce McClain,

References

	Year	Citations

Page 1